Vasoinhibitory Study of Low Molecular Weight Heparins in Human Hepatocellular Carcinoma in Nude Mice
郑起,闫钧,汪昱,陆洪芬,薛琼,汤钊猷
DOI: https://doi.org/10.3781/j.issn.1000-7431.2004.02.012
2004-01-01
Tumori
Abstract:Objective To study the vasoinhibitory effects of low molecular weight heparins in hepatocellular carcinoma (HCC) in nude mice. Methods Metastatic model of HCC was established in nude mice, The model mice were randomly divided into 4 groupsi they were the control group (saline solution) , chemotherapy group (fluorouracil and Cis - dichlorodiamine platinum) , low molecular weight heparins group (Fragmin) ,combined treatment group(both Fragmin and chemotherapy). Follow parame-ters were evaluated respectively, such as tumor size, tumor inhibition rates, tumor metastasis,intratumoral microvessel density (MVD), vascular endothelial growth factor (VEGF) and AFP. Results The control group compared to groups treated with chemotherapy,Fragmin and combined treatment, the tumor size were significantly reduced) the tumor inhibitor rates were 0% versus 93. 62% ,76. 70% ,77. 99% respectively! MVD were 20. 67 ± 6. 80 versus 18. 17 + 2. 64,4. 83 + 1. 830 and 6. 50 ±2. 35; VEGF were 90% ,versus 80%, 30% ,30% i the incidence of liver metastasis was 80% ,versus 70% ,20% and 10% ; Lung metas-tasis was 70% versus 60%,20% and 10% > the peritoneal metastasis was 90% versus 60% ,40%and 40%. AFP were 121. 80 ± 31. 34 ng/ml versus 21. 45 ± 13. 29 ng/ml, 75. 60 ± 29. 74 ng/ml and 55. 82 ± 37. 98 mg/ml. Chemotherapy, low molecular weight heparins and uniting treatment groups comparing with control, inhibiting effects of tumor growth in HCC shows the difference ( P<0. 05), low molecular weight heparins can inhibit validly angiogensis and metastasis in HCC, matched control and pure chemotherapy it was difference Significantly ( P<0. 05). Conclusion Low molecular weight heparins can inhibit tumor growth and metastasis by inhibiting tumor angiogenesis in HCC.